Skip to content

Let me now examine the key aspects of the GO-CAM model I'm reviewing:

Review of GO-CAM Model: gomodel:67086be200002705 "Retinoid Metabolic Process 4 (Mouse)"

Overview

This model represents the retinoid metabolic process in mouse, focusing on the mechanisms by which retinoids (vitamin A and its derivatives) are processed, transported, and metabolized. The model includes various proteins involved in this pathway, such as lipoprotein lipase (Lpl), retinol binding proteins (Rbp1, Rbp2), alcohol dehydrogenase (Adh1), lecithin retinol acyltransferase (Lrat), and other enzymes that participate in retinoid metabolism.

Strengths

  1. Appropriate evidence citations: The model includes evidence from peer-reviewed literature with proper citation of PMIDs.
  2. Detailed molecular activities: The model captures specific molecular activities like lipoprotein lipase activity, retinol binding, retinol dehydrogenase activity, and retinyl-palmitate hydrolase activity.
  3. Appropriate causal connections: The model shows appropriate causal relationships using relation predicates like "provides input for" (RO:0002413) and "directly negatively regulates" (RO:0002630).
  4. Proper context annotations: Activities are properly contextualized with cellular locations (e.g., occurs_in GO:0005576 - extracellular region, GO:0005829 - cytosol) and biological processes (part_of GO:0001523 - retinoid metabolic process).

Areas for Improvement

1. Complex Representation

In the model, there is a chylomicron complex (GO:0042627) that enables retinoid binding. According to the "How to annotate complexes in GO-CAM" guidelines, when the specific subunit carrying the activity is not known, using the GO complex term is appropriate. However, the complex is represented with "members: []" - an empty list. It would be helpful to annotate the known components of this complex if available.

2. Molecular Carrier Activities

The model includes several proteins involved in retinol binding and transport. According to the "Molecular carrier activity" guidelines, carrier proteins that transport small molecules should use: - "has input" relation for the transported molecule - "has output" relation so the small molecule can be input for the next reaction

While some of these relationships are present, others could be more clearly defined. For instance, the model shows Rbp1 (MGI:MGI:97876) with all-trans-retinol binding activity, but the complete carrier pathway could be more explicitly modeled.

3. Input/Output Relationships

Some molecular functions have inputs or outputs specified, but others do not. For complete pathway modeling, it would be beneficial to ensure all relevant inputs and outputs are captured. For example: - Activity 67086be200002723 has appropriate input (CHEBI:17336 - all-trans-retinol) - Activity 67086be200002729 has primary input as CHEBI:17898 (all-trans-retinal) - However, some intermediary activities could have more clearly defined inputs/outputs

4. Evidence Base

While the model uses evidence from multiple PMIDs, examining one of the key papers (PMID:23362116) reveals important mechanistic details about the role of cellular retinol-binding protein (CRBP1/Rbp1) in regulating retinoid metabolism. These mechanistic details from the literature support the model but could be more completely captured in some of the relationships.

Biological Consistency Check

The model represents retinoid metabolism from the initial processing of retinoids by lipoprotein lipase, through binding by carrier proteins, to conversion between different retinoid forms (retinol, retinal, retinoic acid) by appropriate enzymes. This is consistent with what is known about retinoid metabolism:

  1. Retinoids are transported in circulation as retinyl esters in chylomicrons
  2. Retinyl esters can be hydrolyzed to retinol
  3. Retinol is bound by cellular retinol binding proteins
  4. Retinol can be oxidized to retinal by retinol dehydrogenases
  5. Retinal can be further oxidized to retinoic acid
  6. Retinol can also be esterified for storage

These key steps are included in the model, supporting its biological accuracy.

Recommendations

  1. Consider adding more detail to the chylomicron complex representation if component information is available.
  2. Review and ensure all carrier activities follow the molecular carrier activity guidelines, with clear input/output relationships.
  3. Complete any missing input/output annotations for intermediate steps in the pathway.
  4. Consider adding more detailed annotations about the role of Rbp1 in regulating retinoid homeostasis, as supported by the literature evidence.

Conclusion

Overall, the model "Retinoid Metabolic Process 4 (Mouse)" (gomodel:67086be200002705) is a well-constructed representation of retinoid metabolism that follows most GO-CAM best practices. With the suggested improvements, particularly in complex representation and carrier protein modeling, the model could provide an even more complete picture of retinoid metabolism.

The model correctly captures the flow of retinoids from extracellular transport to cellular processing and metabolism, with appropriate causal connections between activities, making it a valuable resource for understanding retinoid metabolism in mouse.